RhumbLine Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
|
|||||
|
2025
Q1 | $306K | Sell |
|
|||||
|
2024
Q4 | $1.54M | Buy |
|
|||||
|
2024
Q3 | $1.39M | Sell |
|
|||||
|
2024
Q2 | $2.38M | Buy |
|
|||||
|
2024
Q1 | $3.16M | Sell |
|
|||||
|
2023
Q4 | $5.25M | Buy |
|
|||||
|
2023
Q3 | $4.41M | Buy |
|
|||||
|
2023
Q2 | $4.83M | Buy |
|
|||||
|
2023
Q1 | $4.37M | Buy |
|
|||||
|
2022
Q4 | $4.96M | Buy |
|
|||||
|
2022
Q3 | $4.04M | Buy |
|
|||||
|
2022
Q2 | $3.59M | Buy |
|
|||||
|
2022
Q1 | $2.07M | Buy |
|
|||||
|
2021
Q4 | $1.85M | Sell |
|
|||||
|
2021
Q3 | $2.48M | Buy |
|
|||||
|
2021
Q2 | $2.36M | Sell |
|
|||||
|
2021
Q1 | $2.15M | Sell |
|
|||||
|
2020
Q4 | $2.31M | Sell |
|
|||||
|
2020
Q3 | $1.95M | Sell |
|
|||||
|
2020
Q2 | $2.89M | Buy |
|
|||||
|
2020
Q1 | $2.41M | Buy |
|
|||||
|
2019
Q4 | $2.92M | Buy |
|
|||||
|
2019
Q3 | $1.84M | Buy |
|
|||||
|
2019
Q2 | $2.24M | Sell |
|
|||||
|
2019
Q1 | $2.5M | Sell |
|
|||||
|
2018
Q4 | $1.93M | Buy |
|
|||||
|
2018
Q3 | $2.31M | Sell |
|
|||||
|
2018
Q2 | $2.56M | Buy |
|
|||||
|
2018
Q1 | $1.97M | Sell |
|
|||||
|
2017
Q4 | $1.96M | Sell |
|
|||||
|
2017
Q3 | $2.46M | Buy |
|
|||||
|
2017
Q2 | $2.91M | Buy |
|
|||||
|
2017
Q1 | $2.57M | Buy |
|
|||||
|
2016
Q4 | $2.2M | Buy |
|
|||||
|
2016
Q3 | $2.17M | Buy |
|
|||||
|
2016
Q2 | $1.75M | Buy |
|
|||||
|
2016
Q1 | $1.38M | Buy |
|
|||||
|
2015
Q4 | $1.43M | Buy |
|
|||||
|
2015
Q3 | $1.16M | Buy |
|
|||||
|
2015
Q2 | $1.31M | Sell |
|
|||||
|
2015
Q1 | $1.83M | Buy |
|
|||||
|
2014
Q4 | $1.44M | Sell |
|
|||||
|
2014
Q3 | $1.26M | Sell |
|
|||||
|
2014
Q2 | $1.5M | Buy |
|
|||||
|
2014
Q1 | $1M | Sell |
|
|||||
|
2013
Q4 | $945K | Sell |
|
|||||
|
2013
Q3 | $971K | Sell |
|
|||||
|
2013
Q2 | $822K | Buy |
|